Detalles de la búsqueda
1.
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
J Antimicrob Chemother
; 68(11): 2626-31, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23798669
2.
Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.
J Neurovirol
; 19(4): 376-82, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23846287
3.
The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review.
Virol J
; 9: 174, 2012 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22925532
4.
Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.
Antimicrob Agents Chemother
; 54(8): 3335-40, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20530226
5.
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.
Antimicrob Agents Chemother
; 54(1): 72-7, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19901096
6.
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
J Antimicrob Chemother
; 65(12): 2620-7, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20965891
7.
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.
J Antimicrob Chemother
; 62(3): 451-5, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18552344
8.
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).
Heliyon
; 3(2): e00245, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224137
9.
Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'.
Heliyon
; 3(3): e00259, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28367507
10.
Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
J Clin Virol
; 78: 27-30, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26967675
11.
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
AIDS
; 29(13): 1665-71, 2015 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26372277
12.
Yeast cells as a tool for analysis of HIV-1 protease susceptibility to protease inhibitors, a comparative study.
J Virol Methods
; 195: 180-4, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24056262
13.
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
AIDS
; 28(4): 493-501, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24472743
14.
HIV-1 and persistent clinical latency, TAR element analysis and improved method for in vitro viral reactivation.
J Clin Virol
; 38(4): 348-52, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17339129
15.
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Antivir Ther
; 17(1): 119-23, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22267476
16.
Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
AIDS
; 30(14): 2257-8, 2016 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27574797
17.
Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.
J Med Virol
; 76(4): 441-6, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15977249
18.
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
J Acquir Immune Defic Syndr
; 38(5): 545-52, 2005 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15793364
19.
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Antimicrob Agents Chemother
; 49(5): 1720-6, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15855487
20.
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients.
J Acquir Immune Defic Syndr
; 34(5): 497-9, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14657760